InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy
NCT:NCT06411548 · COMPLETED
广告
NCT编号NCT06411548
状态COMPLETED
开始日期2025-03-27
完成时间2025-10-17
SponsorUniversity of Virginia (OTHER)
First posted
Last updated
简要摘要
This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。